Compile Data Set for Download or QSAR
maximum 50k data
Found 156 Enz. Inhib. hit(s) with all data for entry = 11585
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629099(3-Chloro-4-[3-(5-fluoro-2-pyridyl)-1-methyl-pyrazo...)
Affinity DataIC50:  17nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629098(3-Bromo-4-[3-(5-fluoro-2-pyridyl)-1-methyl-pyrazol...)
Affinity DataIC50:  24nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629074(4-(3-(5-Fluoropyridin-2-yl)-1,5-dimethyl-1H-pyrazo...)
Affinity DataIC50:  28nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629142(4-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-1...)
Affinity DataIC50:  32nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629103(4-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-6...)
Affinity DataIC50:  41nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629101(5-Fluoro-4-[3-(5-fluoro-2-pyridyl)-1-methyl-pyrazo...)
Affinity DataIC50:  50nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629102(4-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-5...)
Affinity DataIC50:  52nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629100(3-Fluoro-4-[3-(5-fluoro-2-pyridyl)-1-methyl-pyrazo...)
Affinity DataIC50:  53nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629043(4-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-1...)
Affinity DataIC50:  54nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629105(4-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-3...)
Affinity DataIC50:  59nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629043(4-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-1...)
Affinity DataIC50:  70nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629112(4-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-1...)
Affinity DataIC50:  71nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629139(N-(4-(3-(5-Fluoropyridin-2-yl)-1-methyl-1H-pyrazol...)
Affinity DataIC50:  76nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629060(4-[3-(3,5-Difluoro-2-pyridyl)-1-methyl-pyrazol-4-y...)
Affinity DataIC50:  78nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629091(4-[1-(2-Fluoroethyl)-3-(5-fluoro-2-pyridyl)pyrazol...)
Affinity DataIC50:  80nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629078(4-[1-Ethyl-3-(5-fluoro-2-pyridyl)pyrazol-4-yl]-1H-...)
Affinity DataIC50:  93nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629110(4-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-5...)
Affinity DataIC50:  94nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629081(4-[3-(5-Fluoro-2-pyridyl)-1-isopropyl-pyrazol-4-yl...)
Affinity DataIC50:  97nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629151(2-Ethoxy-8-[3-(5-fluoro-2-pyridyl)-1-methyl-pyrazo...)
Affinity DataIC50:  103nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629024(N-(4-(3-(5-Fluoropyridin-2-yl)-1-methyl-1H-pyrazol...)
Affinity DataIC50:  107nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629094(4-(1-Cyclobutyl-3-(5-fluoropyridin-2-yl)-1H-pyrazo...)
Affinity DataIC50:  113nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629084(4-[3-(5-Fluoro-2-pyridyl)-1-isobutyl-pyrazol-4-yl]...)
Affinity DataIC50:  115nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629073(4-[3-(5-Fluoro-2-pyridyl)-1-(oxetan-3-ylmethyl)pyr...)
Affinity DataIC50:  122nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629030(2-(1-Methyl-4-(1H-pyrrolo[2,3-b]pyridin-4-yl)-1H-p...)
Affinity DataIC50:  128nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629095(4-[3-(5-Fluoro-2-pyridyl)-1-(oxetan-3-yl)pyrazol-4...)
Affinity DataIC50:  136nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629111(4-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-1...)
Affinity DataIC50:  144nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629126(8-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-2...)
Affinity DataIC50:  147nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629119(3-(4-(3-(5-Fluoropyridin-2-yl)-1-methyl-1H-pyrazol...)
Affinity DataIC50:  148nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629051(4-[3-(6-Fluoro-3-pyridyl)-1-methyl-pyrazol-4-yl]-1...)
Affinity DataIC50:  165nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629088(4-[1-(Difluoromethyl)-3-(5-fluoro-2-pyridyl)pyrazo...)
Affinity DataIC50:  171nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629050(4-[3-(4-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-1...)
Affinity DataIC50:  178nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629038(3-(1-Methyl-4-(1H-pyrrolo[2,3-b]pyridin-4-yl)-1H-p...)
Affinity DataIC50:  181nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629115(4-(3-(5-Fluoropyridin-2-yl)-1-methyl-1H-pyrazol-4-...)
Affinity DataIC50:  184nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629052(4-[3-(6-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-1...)
Affinity DataIC50:  186nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629117(3-(4-(3-(5-Fluoropyridin-2-yl)-1-methyl-1H-pyrazol...)
Affinity DataIC50:  187nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629123(4-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-3...)
Affinity DataIC50:  197nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629079(4-(1-Ethyl-3-(5-fluoropyridin-2-yl)-1H-pyrazol-4-y...)
Affinity DataIC50:  205nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629097((R/S)-4-[3-(5-Fluoro-2-pyridyl)-1-tetrahydrofuran-...)
Affinity DataIC50:  218nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629080(4-(1-Ethyl-3-(5-fluoropyridin-2-yl)-1H-pyrazol-4-y...)
Affinity DataIC50:  219nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629107(2-(Difluoromethyl)-4-(3-(5-fluoropyridin-2-yl)-1-m...)
Affinity DataIC50:  224nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629075(4-(5-Cyclobutyl-3-(5-fluoropyridin-2-yl)-1-methyl-...)
Affinity DataIC50:  227nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629146(4-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-2...)
Affinity DataIC50:  234nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629093(4-(3-(5-Fluoropyridin-2-yl)-1-(2,2,2-trifluoroethy...)
Affinity DataIC50:  236nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629122(4-(3-(5-Fluoropyridin-2-yl)-1-methyl-1H-pyrazol-4-...)
Affinity DataIC50:  238nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629047(4-[3-(5-Chloro-2-pyridyl)-1-methyl-pyrazol-4-yl]-1...)
Affinity DataIC50:  251nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629086(4-(3-(5-Fluoropyridin-2-yl)-1-isobutyl-1H-pyrazol-...)
Affinity DataIC50:  253nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629108(4-(3-(5-Fluoropyridin-2-yl)-1-methyl-1H-pyrazol-4-...)
Affinity DataIC50:  255nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629130(4-[3-(5-Fluoro-2-pyridyl)-1-methyl-pyrazol-4-yl]-7...)
Affinity DataIC50:  264nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629066(4-[3-(5-Fluoropyrimidin-2-yl)-1-methyl-pyrazol-4-y...)
Affinity DataIC50:  268nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCasein kinase I isoform delta(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM629063(4-(3-(5-Fluoro-6-methylpyridin-2-yl)-1-methyl-1H-p...)
Affinity DataIC50:  288nMAssay Description:In this assay, CSNK1D phosphorylates a substrate peptide PLSRTL-pS-VASLPGL in the presence of ATP. This substrate peptide has been modeled after the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 156 total ) | Next | Last >>
Jump to: